4.6 Article

Localized In Situ Nanoemulgel Drug Delivery System of Quercetin for Periodontitis: Development and Computational Simulations

Journal

MOLECULES
Volume 23, Issue 6, Pages -

Publisher

MDPI
DOI: 10.3390/molecules23061363

Keywords

nanoemulgel; periodontitis; spontaneous emulsification; antimicrobial; molecular simulation; computational formulation design

Ask authors/readers for more resources

This study was aimed at formulating a bioabsorbable, controlled-release, nanoemulgel of Quercetin, a potent antimicrobial and anti-inflammatory agent for the treatment of periodontitis that could improve its solubility and bioavailability. Screening of components was carried out based on the solubility studies. Nanoemulsion containing cinnamon oil as the oil phase, tween 80 and Carbitol (R) as the surfactant-cosurfactant mixture (S-mix) and water as the aqueous phase containing 125 mu g/200 mu L of Quercetin was prepared by using spontaneous emulsification method. Nanoemulgel was prepared using 23% w/v poloxamer 407 as gel base. Comprehensive evaluation of the formulated nanoemulgel was carried out, and the optimized formulation was studied for drug release using Franz vertical diffusion cells. The formulated nanoemulgelexhibited a remarkable release of 92.4% of Quercetin at the end of 6 h, as compared to that of pure Quercetin-loaded gel (<3% release). The viscosity of the prepared nanoemulgel was found to be 30,647 +/- 0.32 cPs at 37 degrees C. Also, molecular dynamics (MD) simulation was utilized to understand the gelation process and role of each component in the formulation. The present study revealed that the developed nanoemulgel of Quercetin could be a potential delivery system for clinical testing in periodontitis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Design, development and evaluation of Resveratrol transdermal patches for breast cancer therapy

Shivaprasad Gadag, Reema Narayan, Yogendra Nayak, Sanjay Garg, Usha Y. Nayak

Summary: This study developed a transdermal patch of resveratrol (RVT) for site-specific delivery in breast cancer therapy. The patch containing HPMC E15LV, HPMC-K4M, and PVP K30 as release controlling polymers showed the best permeation of RVT. In vivo studies demonstrated higher breast tissue disposition and reduced tumor volume and serum CA 15-3 levels compared to oral administration of RVT.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Article Virology

Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment

Varalakshmi Velagacherla, Akhil Suresh, Chetan Hasmukh Mehta, Usha Y. Nayak, Yogendra Nayak

Summary: COVID-19, caused by SARS-CoV-2, is a global pandemic that originated in Wuhan, China. Drug discovery teams worldwide are racing to find a treatment for this disease. Repurposing already approved drugs is an ideal approach to expedite the process. We used the Schrodinger suite for in silico predictions to screen selected molecules with an affinity for multiple protein targets in COVID-19. Through molecular docking, MM-GBSA, IFD, and MD simulations, we identified nintedanib as the most suitable molecule with high binding stability to viral proteins. Nintedanib, primarily used for idiopathic pulmonary fibrosis, shows potential for repurposing against COVID-19.

VIRUSES-BASEL (2023)

Review Pharmacology & Pharmacy

Advanced Strategies of Drug Delivery via Oral, Topical, and Parenteral Administration Routes: Where Do Equine Medications Stand?

Yunmei Song, Candace M. Day, Franklin Afinjuomo, Jin-Quan E. Tan, Stephen W. Page, Sanjay Garg

Summary: While the veterinary product market is growing rapidly, there is a lack of specialized knowledge in equine pharmaceutics. The similarity between horse and human anatomy allows for repurposing of human dosage forms for equine medications, but physiological variation makes therapeutic outcomes unpredictable. Research is needed to address the deficiency in literature precedence on drug delivery for horses. Novel drug delivery systems can be developed by evaluating equine anatomy and physiology to better treat medical ailments in horses. NDDSs not only enhance the duration of drug action, but also improve owner compliance and convenience of administration.

PHARMACEUTICS (2023)

Article Veterinary Sciences

Physicochemical properties of otic products for Canine Otitis Externa: comparative analysis of marketed products

Yunmei Song, Sadikalmahdi Abdella, Franklin Afinjuomo, Emily Josephine Weir, Jin Quan Eugene Tan, Peter Hill, Stephen W. Page, Sanjay Garg

Summary: This study compared the physicochemical properties of nine commercially available otic veterinarian products in Australia used to manage canine otitis externa (COE). The results showed that products containing polymers had higher viscosity and bio-adhesion, while spreadability was inversely related to viscosity. Aqueous-based otic products showed better syringebility, while oil-based systems required higher force to expel the products. Variability in droplet size was observed, with Derm Otic, Baytril Otic, and Aurizon Ear Drops showing lower standard deviation, indicating a more consistent dose.

BMC VETERINARY RESEARCH (2023)

Review Chemistry, Inorganic & Nuclear

Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives

Neha Benedicta Fernandes, Yogendra Nayak, Sanjay Garg, Usha Y. Nayak

Summary: The field of advanced nanotechnology offers a wide range of nanotheranostics for treating malignant tumors. Among them, Mesoporous Silica Nanoparticles (MSNs) combined with upconversion nanoparticles have gained prominence in biomedicine research due to their remarkable properties in drug targeting, bio-imaging, and photodynamic/photothermal therapy. MSNs have versatile pore sizes, high drug loading efficiency, and can be functionalized to enhance their applicability. This article focuses on MSN-based hybrid nanotheranostics and their designing strategies, characterization, applications, efficacy, limitations, biotoxicity, as well as current challenges and future perspectives.

COORDINATION CHEMISTRY REVIEWS (2023)

Article Biochemistry & Molecular Biology

In-silico lead identification of the pan-mutant IDH1 and IDH2 inhibitors to target glioblastoma

E. Vignesh Balaji, Sairaj Satarker, B. Harish Kumar, Samyak Pandey, Sumit Raosaheb Birangal, Usha Y. Nayak, K. Sreedhara Ranganath Pai

Summary: This study aimed to identify novel molecules that could simultaneously inhibit IDH1 and IDH2 for the management of glioblastoma and other cancers. Through molecular docking, simulations, and molecular dynamics analysis, four potential compounds were identified. These compounds showed maximum interaction with crucial amino acids in IDH1 and IDH2 and could potentially combat glioblastoma. However, further in vitro and in vivo studies are needed to validate the findings of this study.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Immunology

Polyphenol-based targeted therapy for oral submucous fibrosis

Chetan Hasmukh Mehta, Shivangi Paliwal, Manjunatha S. Muttigi, Raviraja N. Seetharam, Alevoor Srinivas Bharath Prasad, Yogendra Nayak, Shruthi Acharya, Usha Yogendra Nayak

Summary: Oral submucous fibrosis (OSF) is a chronic and precancerous condition caused by chewing areca nut, and current therapy has limited success. In this study, a combined approach of in silico, in vitro and in vivo methods was used to select the most suitable polyphenols for OSF treatment. Epigallocatechin-3-gallate (EGCG), quercetin (QUR), resveratrol, and curcumin showed high affinity and stability with the selected protein targets. In vitro and in vivo studies demonstrated that EGCG was safer and more effective in reducing fibrosis-related markers than QUR. The findings suggest that EGCG can be a potential and safer phytomolecule for OSF therapy.

INFLAMMOPHARMACOLOGY (2023)

Review Pharmacology & Pharmacy

The Management of Parkinson's Disease: An Overview of the Current Advancements in Drug Delivery Systems

Deepa D. Nakmode, Candace M. Day, Yunmei Song, Sanjay Garg

Summary: Parkinson's disease has had significant impact on a large portion of the elderly population worldwide, with an estimated 8.5 million people living with the disease globally. In the United States, approximately one million people are living with Parkinson's disease, and 60,000 new cases are diagnosed each year. This review focuses on the latest advances in drug delivery systems (DDSs) to address the limitations of current therapies, and discusses the promising features and drawbacks of these advancements. The technical properties, mechanism, and release patterns of incorporated drugs, as well as nanoscale delivery strategies to overcome the blood-brain barrier, are of particular interest.

PHARMACEUTICS (2023)

Review Pharmacology & Pharmacy

Transforming Wound Management: Nanomaterials and Their Clinical Impact

T. Ashwini, Ashlesh Prabhu, Vishal Baliga, Shreesha Bhat, Siddarth T. Thenkondar, Yogendra Nayak, Usha Y. Nayak

Summary: Wound healing is a complex process that can be further complicated in chronic wounds. Nanotechnology has shown great promise in developing advanced wound dressings. This review article provides a comprehensive search strategy and an updated overview of the different types of nanomaterials used in wound dressings. It also highlights the potential benefits of using nanomaterials in wound care and serves as a valuable resource for clinicians, researchers, and patients.

PHARMACEUTICS (2023)

Review Agriculture, Dairy & Animal Science

Application of Exogenous GnRH in Food Animal Production

A. H. M. Musleh Uddin, Kiro R. Petrovski, Yunmei Song, Sanjay Garg, Roy N. Kirkwood

Summary: Optimal fertility in food-producing animals can be achieved by using exogenous GnRH and agonists to control ovulation timing and promote reproductive success. GnRH administration is used to counter ovarian dysfunction, induce ovulation, and increase conception and pregnancy rates in animals. Exogenous GnRH products are commonly used in pre- and post-breeding programs to enhance fertility and treat reproductive morbidities.

ANIMALS (2023)

Article Microbiology

Oral administration of a 2-aminopyrimidine robenidine analogue (NCL1 95) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub -inhibitory colistin concentrations in a bioluminescent mouse model

Hang Thi Nguyen, Henrietta Venter, Lucy Woolford, Kelly A. Young, Adam Mccluskey, Sanjay Garg, Sylvia S. Sapula, Stephen W. Page, Abiodun David Ogunniyi, Darren J. Trott

Summary: This study confirms that NCL195 is a potential candidate for treating multidrug-resistant infections, either as a standalone antibiotic for Gram-positive bacteria or in combination with sub-inhibitory concentrations of colistin for Gram-negative bacteria.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Instruments & Instrumentation

Combining the potential of 3D printed buccal films and nanostructured lipid carriers for personalised cannabidiol delivery

Sadikalmahdi Abdella, Sangseo Kim, Franklin Afinjuomo, Yunmei Song, Richard Upton, Sanjay Garg

Summary: This study optimized and developed buccal film loaded with CBD-NLCs using Design of Experiments (DoE), lipid carriers, and 3D printing techniques. The CBD-NLCs film demonstrated a slow and sustained in vitro release, indicating potential applications for oral drug delivery.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2023)

Review Pharmacology & Pharmacy

Innovative Topical Patches for Non-Melanoma Skin Cancer: Current Challenges and Key Formulation Considerations

Sangseo Kim, Candace M. Day, Yunmei Song, Amy Holmes, Sanjay Garg

Summary: Non-melanoma skin cancer (NMSC) is a common malignancy globally, and topical treatment is a key management strategy. However, conventional topical treatments often face challenges such as poor drug penetration and patient adherence. To overcome these limitations, researchers have started using advanced topical patches for the treatment of NMSC. This review provides an overview of NMSC and the current landscape of topical treatments, focusing on the emerging technology of topical patches, and discusses their potential to improve existing therapies.

PHARMACEUTICS (2023)

Article Chemistry, Multidisciplinary

Nanotechnology and narasin: a powerful combination against acne

Fatima Abid, Bhumika Savaliya, Ankit Parikh, Sangseo Kim, Marzieh Amirmostofian, Laura Cesari, Yunmei Song, Stephen W. W. Page, Darren J. J. Trott, Sanjay Garg

Summary: In order to improve the clinical management of acne, there is a need for innovative antibacterial therapies that utilize novel mechanisms. This study found that narasin (NAR) has promising antibacterial activity against drug-resistant acne bacteria. By formulating NAR into self-nanomicellizing solid dispersions (SNMSD) and using micelles as drug carriers, the aqueous solubility of NAR was significantly increased and targeted delivery to the lipophilic skin layers was achieved.

NANOSCALE (2023)

No Data Available